The Bidirectional Relationship between Diabetes and Depression: A Literature Review

키워드

참고문헌 (60)

1. NCD Risk Factor Collaboration (NCD-RisC), "Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants", Lancet, 387, pp.1513~1530 (2016)[DOI]
2. Osborn DP, "Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis", BMC Psychiatry, 8, pp.84~ (2008)[DOI]
3. American Psychiatric Association, "DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Association
4. Gavard JA, "Prevalence of depression in adults with diabetes: an epidemiological evaluation", Diabetes Care, 16, pp.1167~1178 (1993)[DOI]
5. Anderson RJ, "The prevalence of comorbid depression in adults with diabetes: a meta-analysis", Diabetes Care, 24, pp.1069~1078 (2001)[DOI]
6. Ali S, "The prevalence of comorbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis", Diabet Med, 23, pp.1165~1173 (2006)[DOI]
7. Palinkas LA, "Type 2 diabetes and depressive symptoms in older adults: a population-based study", Diabet Med, 8, pp.532~539 (1991)[DOI]
8. Lin EH, "Mental disorders among persons with diabetes: results from the World Mental Health Surveys", J Psychosom Res, 65, pp.571~580 (2008)[DOI]
9. Lopes A, "Association between major depression and type 2 diabetes mellitus: a meta-analysis and meta-regression of observational studies", Int Arch Med, 9, pp.1~11 (2016)[DOI]
10. Mendenhall E, "Depression and type 2 diabetes in low- and middle-income countries: a systematic review", Diabetes Res Clin Pract, 103, pp.276~285 (2014)[DOI]
11. Nouwen A, "Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis", Diabetologia, 53, pp.2480~2486 (2010)[DOI]
12. Palinkas LA, "A prospective study of type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study", Diabet Med, 21, pp.1185~1191 (2004)[DOI]
13. Engum A, "The role of depression and anxiety in onset of diabetes in a large population-based study", J Psychosom Res, 62, pp.31~38 (2007)[DOI]
14. Golden SH, "Examining a bidirectional association between depressive symptoms and diabetes", JAMA, 299, pp.2751~2759 (2008)[DOI]
15. Mezuk B, "Depression and type 2 diabetes over the lifespan: a meta-analysis", Diabetes Care, 31, pp.2383~2390 (2008)[DOI]
16. Zhuang QS, "Quantitative assessment of the bidirectional relationships between diabetes and depression", Oncotarget, 8, pp.23389~23400 (2017)
17. Vancampfort D, "Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors", Depress Anxiety, 32, pp.763~773 (2015)[DOI]
18. Eaton WW, "Depression and risk for onset of type II diabetes: a prospective population-based study", Diabetes Care, 19, pp.1097~1102 (1996)[DOI]
19. Knol MJ, "Depression as a risk factor for the onset of type 2 diabetes mellitus: a meta- analysis", Diabetologia, 49, pp.837~845 (2006)[DOI]
20. Schmitz N, "Depression and risk of type 2 diabetes: the potential role of metabolic factors", Mol Psychiatry, 21, pp.1726~1732 (2016)[DOI]
21. Virtanen M, "Metabolic syndrome and symptom resolution in depression: a 5-year follow-up of older adults", J Clin Psychiatry, 78, pp.e1~e7 (2017)[DOI]
22. Lustman PJ, "Depression and poor glycemic control: a meta-analytic review of the literature", Diabetes Care, 23, pp.934~942 (2000)[DOI]
23. Richardson LK, "Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes", Gen Hosp Psychiatry, 30, pp.509~514 (2008)[DOI]
24. Aikens JE, "Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes", Diabetes Care, 32, pp.1177~1181 (2009)[DOI]
25. Fisher L, "Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses", Diabetes Care, 33, pp.23~28 (2010)[DOI]
26. Lin EH, "Relationship of depression and diabetes self-care, medication adherence, and preventive care", Diabetes Care, 27, pp.2154~2160 (2004)[DOI]
27. Gonzalez JS, "Depression and diabetes treatment nonadherence: a meta-analysis", Diabetes Care, 31, pp.2398~2403 (2008)[DOI]
28. Lin EH, "Depression and advanced complications of diabetes: a prospective cohort study", Diabetes Care, 33, pp.264~269 (2010)[DOI]
29. De Groot M, "Association of depression and diabetes complications: a meta-analysis", Psychosom Med, 63, pp.619~630 (2001)[DOI]
30. Van Dooren FE, "Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis", PLoS One, 8, pp.e57058~ (2013)[DOI]
31. Coleman SM, "Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort", Psychosomatics, 54, pp.428~436 (2013)[DOI]
32. Zhang X, "Depressive symptoms and mortality among persons with and without diabetes", Am J Epidemiol, 161, pp.652~660 (2005)[DOI]
33. Uchendu C, "Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials", Diabet Med, 34, pp.328~339 (2017)[DOI]
34. Turkington RW, "Depression masquerading as diabetic neuropathy", JAMA, 243, pp.1147~1150 (1980)[DOI]
35. Lustman PJ, "Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial", Psychosom Med, 59, pp.241~250 (1997)[DOI]
36. Lustman PJ, "Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial", Diabetes Care, 23, pp.618~623 (2000)[DOI]
37. Lustman PJ, "Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial", Arch Gen Psychiatry, 63, pp.521~529 (2006)[DOI]
38. Paile-Hyvarinen M, "Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial", BMC Fam Pract, 4, pp.7~ (2003)[DOI]
39. Amsterdam JD, "Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus", Neuropsychobiology, 54, pp.208~214 (2006)[DOI]
40. Lustman PJ, "Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion", Diabetes Care, 30, pp.459~466 (2007)[DOI]
41. Colle R, "Pioglitazone could induce remission in major depression: a metaanalysis", Neuropsychiatr Dis Treat, 13, pp.9~16 (2016)[DOI]
42. Guo M, "Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus", Clin Exp Pharmacol Physiol, 41, pp.650~656 (2014)
43. Haapakoski R, "Cumulative meta-analysis of interleukins 6 and 1b, tumour necrosis factor a and C-reactive protein in patients with major depressive disorder", Brain Behav Immun, 49, pp.206~215 (2015)[DOI]
44. Khandaker GM, "Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study", JAMA Psychiatry, 71, pp.1121~1128 (2014)[DOI]
45. Wang X, "Inflammatory markers and risk of type 2 diabetes: a systematic review and metaanalysis", Diabetes Care, 36, pp.166~175 (2013)[DOI]
46. Au B, "C-reactive protein, depressive symptoms, and risk of diabetes: results from the English Longitudinal Study of Ageing (ELSA)", J Psychosom Res, 77, pp.180~186 (2014)[DOI]
47. Herder C, "Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes", Brain Behav Immun, 61, pp.137~145 (2017)[DOI]
48. Stetler C, "Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research", Psychosom Med, 73, pp.114~126 (2011)[DOI]
49. Roy M, "Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients", Psychiatry Res, 31, pp.31~37 (1990)[DOI]
50. Bruehl H, "A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus", Psychoneuroendocrinology, 34, pp.815~821 (2009)[DOI]
51. Spanakis EK, "Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis", Endocrine, 53, pp.227~239 (2016)[DOI]
52. Yokoyama K, "Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression", Psychiatry Res, 226, pp.494~498 (2015)[DOI]
53. Gragnoli C, "Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome", Appl Clin Genet, 7, pp.43~53 (2014)
54. German J, "Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve", Endocrinology, 150, pp.4502~4511 (2009)[DOI]
55. Jow GM, "Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia", J Affect Disord, 90, pp.21~27 (2006)[DOI]
56. Chirinos DA, "Leptin and its association with somatic depressive symptoms in patients with the metabolic syndrome", Ann Behav Med, 46, pp.31~39 (2013)[DOI]
57. Chen GC, "Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis", Obes Rev, 15, pp.134~142 (2014)[DOI]
58. Haleem DJ, "Fasting leptin and glucose in normal weight, over weight and obese men and women diabetes patients with and without clinical depression", Metab Brain Dis, 32, pp.757~764 (2017)[DOI]
59. Samaan Z, "Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic population", Transl Psychiatry, 5, pp.e618~ (2015)[DOI]
60. Clarke TK, "Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort", Am J Med Genet B Neuropsychiatr Genet, 174, pp.227~234 (2017)[DOI]

관련 논문AI추천